Skip to main content

Table 3 Discharge on oral therapy criteria

From: A new approach to treatment of resistant gram-positive infections: potential impact of targeted IV to oral switch on length of stay

1. Clinical status

• Afebrile for at least 48 hours

• Tolerates normal diet

• IV access only required for glycopeptide therapy

• Physically independent/well enough for residential/nursing home care

2. Clinical team discharge policy

• A YES answer to the question: "If this patient was on an equally effective oral antibiotic, could they be discharged today?"